Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cbd - search results
If you're not happy with the results, please do another search
TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?
BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).
Can cannabidiol treat Type 2 diabetes?
Delve into the story of Kevin Simpson, who used Cannabidiol (CBD) to treat Type 2 Diabetes.
European regulatory environment acting as driver of fintech innovation
Susan Friedman, Head of Public Policy, Ripple, discusses how European regulation acts as a driver for fintech innovation.
High stakes: Is the UK finally clearing a pathway for cannabis investments?
John Binns, Partner at BCL Solicitors LLP says it’s high stakes when it comes to the UK finally clearing a pathway towards cannabis investments.
Ensuring regulatory compliance for Medical Cannabis
Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
Will 2021 see the UK’s cannabis industry bloom?
John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
The changing perspective of psychedelic drugs with a history of abuse
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
Cannabidiol, skin homeostasis and acne
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
Functionality of Hemp Proteins and their Peptides
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
Why COVID might actually save the NHS
The rise of the virtual ward is charted here by Max Mckiernan, L2S2’s Marketing Manager and Jane Aldridge, Co-Founder/CBDO/CFO, including analysis of why COVID may save the NHS.
Innovative Pioneers of the Hemp Trade
Elixinol, Merges Water-Soluble Technology with THC-Free CBD in a New Range of CBD Blended Tinctures.
A vision of a world free from the effects of multiple sclerosis
Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.
The use of medical cannabis in the UK
Andreas Met, COO, Compliance and Director at Halo Labs highlights how the use of medical cannabis is on the rise in the UK and could offer relief to many NHS patients.
A medical professional’s opinion on medical marijuana
Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.
The priorities for cannabis research
Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
Can the UK’s post-COVID-19 economy benefit from a booming medical cannabis industry?
Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
